(US) Brigham Minerals, Inc. engages in the acquisition and managing a a portfolio of mineral and royalty interests. Its portfolio include basins in the United States, which comprises Permian Basin in Texas and New Mexico; the SCOOP and STACK plays in the Anadarko Basin of Oklahoma; the DJ Basin in Colorado; and Wyoming and the Williston Basin in North Dakota. The company was founded by Ben M. Brigham in November 2012 and is headquartered in Austin, TX.
(US) Blackrock TCP Capital Corp. is a specialty finance company, which is focused on direct lending to middle-market companies as well as small businesses. The firm lends primarily to companies with established market positions, strong regional or national operations, differentiated products and services and sustainable competitive advantages, investing across industries in which it has significant knowledge and expertise. Its investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. The company was founded on April 2, 2012 and is headquartered in Santa Monica, CA.
(US) Kimbell Royalty Partners LP engages in owning and acquiring mineral and royalty interests in oil and natural gas properties. The company was founded on October 30, 2015 and is headquartered in Fort Worth, TX.
SWK Holdings Corp. is engaged in the business of financial and asset management in the field of pharmaceutical. The company offers capital and investments in life science companies, institutions and inventors. It engages in royalty purchases and financings, as well as commercialization of products. The firm operates through the following segments: Finance Receivables and Pharmaceutical Development. The Finance Receivables segment is a healthcare capital provider which offers customized financing solutions to a broad range of life science companies, institutions and inventors. It is primarily focused on monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. The Pharmaceutical Development segment strategy is to utilize the Peptelligence platform to create a wholly-owned portfolio of milestone and royalty income by out-licensing the technology. The company was founded in July 1996 and is headquartered in Dallas, TX.